 | | Cobicistat |  | | Published
October 15, 2012 | Susa Coffey, MD
http://hivinsite.ucsf.edu/InSite?page=ar-06-02 | | | Selected Reference | | 3. | DeJesus E, Rockstroh JK, Henry K, et al; GS-236-0103 Study Team. Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate versus ritonavir-boosted atazanavir plus co-formulated emtricitabine and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3, non-inferiority trial. Lancet. 2012 Jun 30;379(9835):2429-38. | |
|
|
|
